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To study the role of human papillomavirus (HPV) infection in the development of genetic instability, we transduced normal human airway
and anogenital epithelial cells with various combinations of HPV-16 E6, E7, and the reverse transcriptase component of telomerase (hTERT).
Cell lines generated by co-expression of E7 with E6 and/or hTERT (i.e., E6/E7, E7/hTERT, and E6/E7/hTERT) exhibited extra copies of
chromosome 20 and specific amplification of the 20q12-ter region, whereas those generated without E7 (i.e., hTERT alone or E6/hTERT) did
not. Co-expression of hTERT and a dominant-negative version of cdk4 that has been shown to inactivate the retinoblastoma (pRb) pathway
also resulted in 20q amplification. Interestingly, extra copies of chromosome 20 were observed in early passage keratinocytes that expressed
E7 alone, and microarray expression analysis revealed that genes in the 20q region and on chromosome 5 were specifically upregulated in
these cells. Our results indicate that chromosome 20q amplification is an early event that may be specifically caused by expression of E7
through inactivation of the pRb pathway in human epithelial cells.
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Human papillomaviruses (HPVs) are involved in the
development of several different epithelial malignancies
(Franceschi et al., 1996; Howley, 1991). The association of
HPV with cervical cancer and other anogenital cancers is
well known, with up to 99% of cervical cancers containing
high-risk HPV sequences (Walboomers et al., 1999). There
is now considerable evidence that high-risk HPV types can
also play a role in the development of certain head and neck0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.06.027
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E-mail address: Al-Klingelhutz@uiowa.edu (A.J. Klingelhutz).cancers, including tonsillar, laryngeal, and some respiratory
carcinomas (Gillison et al., 2000; van Houten et al., 2001).
As with cervical cancer, the most common HPV type found
in these malignancies is HPV-16. The main transforming
genes of HPV are E6, which, among other functions,
degrades the p53 tumor suppressor protein and activates
telomerase, and E7, which is known to inactivate the
retinoblastoma (pRb) protein (Dyson et al., 1989; Klingel-
hutz et al., 1996; Scheffner et al., 1990). Head and neck
cancers that are HPV positive and express E6 and E7
generally do not have mutations in genes involved in the
p53 and pRb pathways, while HPV-negative cancers have a
high incidence of p53 mutation and often lack expression of
p16INK4a, an inhibitor of the cdk4/cyclin D complex that05) 237 – 244
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2002). A recent study examining head and neck cancers
found that HPV-positive and HPV-negative cancers exhibit
different chromosome aberrations (Braakhuis et al., 2004).
These results indicate that HPV-positive and HPV-negative
cancers are distinctly different entities.
Both HPV E6 and E7 have been shown to be involved in
the development of genetic instability. For example, it has
been demonstrated that HPV-16 E7 expression causes
centrosome abnormalities that can lead to aneuploidy
(Duensing and Munger, 2003; Duensing et al., 2001;
Southern et al., 2004). HPV-16 E6 has been implicated in
inducing premature mitotic chromosome segregation as well
as anaphase bridge formation (Duensing and Munger, 2002;
Plug-Demaggio and McDougall, 2002). Thus, expression of
HPV E6 and E7 not only initiates the process of trans-
formation but also creates an environment that can lead to
genetic instability and malignant progression.
Chromosome 20 gain has been observed to be
associated with HPV-mediated immortalization of uroepi-
thelial cells, prostate epithelial cells, and ovarian epithelial
cells (Cuthill et al., 1999; Jin et al., 2004; Macoska et al.,
2000; Savelieva et al., 1997). It has been proposed that
chromosome 20q amplification, in the context of E7
expression, represents a dominant genetic alteration that
is necessary for immortalization (Cuthill et al., 1999).
Amplification of chromosome 20 has also been observed
in breast cancer, bladder cancer, and head and neck
cancers, and several different genes on chromosome 20q
have been found to be upregulated in cell lines and
cancers that exhibit chromosome 20 amplification,
although the role of these genes in transformation remains
controversial (Collins et al., 1998; Gollin, 2001; Guo et
al., 2004; Hodgson et al., 2003; Reshmi et al., 2004). In
this study, we show that expression of HPV-16 E7 is
associated with amplification of the 20q region in human
airway epithelial cells and human foreskin keratinocytes.
Our data indicate that chromosome 20 abnormalities and
amplification of genes on chromosome 20 are an early
event in the process of transformation by E7 and may be a
specific consequence of E7 expression associated with
pRb inactivation.Results
Our previous work demonstrated that adult human
airway epithelial (HAE) cells could be efficiently immor-
talized by co-expressing HPV-16 E6/E7 and hTERT
(Zabner et al., 2003). Using this strategy, independent
immortal HAE cell lines derived from six different donors
were generated. Examination of these cell lines revealed
specific cytogenetic abnormalities. In particular, extra
copies of chromosomes 5 and 20 were observed in all the
cell lines (Zabner et al., 2003). Of particular interest was
that none of the E6/E7/hTERT HAE lines went through acrisis (slow down in growth) during the immortalization
process that would indicate a requirement for other
alterations aside from those conferred by expression of
E6, E7, and hTERT. Thus, the acquisition of chromosomes
5 and 20 abnormalities in these cells did not appear to be a
rare rate-limiting event.
To determine what factors were specifically involved in
the development of chromosome aberrations during the
immortalization process, we transformed early passage
HAE by using various combinations of retroviruses
containing E6, E7, and hTERT. After introduction of the
different genes by retroviral transduction and selection in
appropriate antibiotics, the cells were passaged to deter-
mine whether they had an extended lifespan. Cells that
were transduced with vector alone, E6 alone, or E7 alone
senesced, whereas transduction of E6 and E7 together
resulted in cell lines with a significantly extended lifespan
of greater than 100 population doublings (pd) (Fig. 1A).
Transduction of hTERT alone also resulted in a signifi-
cantly extended lifespan of greater than 100 pd but only
after a crisis period at approximately 65 pd (Fig. 1B). Co-
expression of hTERT with E6, E7, or E6/E7 resulted in
efficient extension of lifespan without an apparent crisis,
although E7/hTERT cells had a slower growth rate overall
(Fig. 1B). All transduced cells that reached 100 pd or
more continue to proliferate in culture and are apparently
immortal. A more detailed characterization of the immor-
tal HAE cells will be reported elsewhere (unpublished
data). Karyotype analysis revealed that all extended
lifespan cells that expressed E7 had extra copies of
chromosome 20, whereas extended lifespan cells that were
transduced with hTERT alone or a combination of E6 and
hTERT did not (Table 1). This was apparent in two
independently derived E7/hTERT and hTERT-transduced
cell lines. To determine whether the chromosome 20
defect was associated with inactivation of the pRb
pathway, we also transduced HAE using a combination
of hTERT with a dominant-negative version of cdk4,
R24C, which has been shown to be constitutively active
in phosphorylating and inactivating pRb (Wei et al.,
2003). HAE cells generated using R24C and hTERT also
exhibited an extra copy of chromosome 20, suggesting
that R24C and E7 may be similar with regard to their
association with the chromosome 20 abnormality (Table
1). All of the cell lines except E6/hTERT also had extra
copies of chromosome 5 (Table 1).
FISH analysis was used to characterize the chromosome
defects in the cells in more detail. Using a 20q12 probe
(20q) and a chromosome 20 centromeric probe (20cen), it
was found that a large number of interphase nuclei in E7
expressing cells exhibited specific amplification of the 20q
region beyond that observed by karyotype analysis (Fig.
2A). This was particularly evident in E7/hTERT cells where
some nuclei had 4- or 5-fold increases in 20q signals as
compared to 20cen signals (Fig. 2B). Overall, amplification
of the 20q region was specifically observed in E7/hTERT,
Fig. 1. Effects of HPVoncogenes and hTERT on growth of airway epithelial (HAE) cells. (A) Growth of HAE transduced with vector alone, HPV-16 E6, HPV-
16 E7, or HPV-16 E6/E7. Only those cells that expressed both E6 and E7 became immortal. (B) Growth of HAE transduced with hTERT and E6, E7, or E6/E7.
Those cells expressing hTERT alone exhibited a crisis before reaching 100 pd, whereas those cells that co-expressed hTERT with any of the viral oncogenes
reached 100 pd without any significant slow down in growth after the initial transduction and selection period between pd10 and pd15.
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extra copies were not generally observed in cells expressing
E6/hTERT or hTERT alone. Identical results were obtained
with a 20qter probe (data not shown). Thus, amplification of
the 20q12-qter region was specifically associated with
expression of E7 or R24C. Extra copies of chromosome 5,
on the other hand, were evident in all of the cell lines except
E6/hTERT, and chromosome 5 copy numbers, as ascer-
tained by FISH, were the same as what was observed by
karyotype analysis (data not shown).To determine whether chromosome 20q amplification
was associated with E7 expression in another cell type, we
also examined human foreskin keratinocytes (HFK) that
were transduced by E6/E7, E7/hTERT, R24C/hTERT, or
hTERT alone. As with HAE, the E6/E7 E7/hTERT, and
R24C/hTERT cell lines exhibited extra copies of chromo-
some 20, whereas cells transfected with vector alone or
immortalized by hTERT alone did not (Table 2).
In a previous study, we reported the results of a
microarray expression analysis of HFK transduced with
Table 1
Karyotype analysis of HAE cells transduced with combinations of E6, E7,
TERT, and R24C
Cell typea Karyotypeb
Vectorc 46, XX[20]
E6/E7 48, XX, +5, +20[15]
E7/hTERT-1 95–105, XXXX, +5, +6, +7, +11, 16,
+18, +20, +20[cp10]d
E7/hTERT-2 48, XX, +7, +20, add(22)(q13)[10]
E6/hTERT 46, XX, der(22)t(1;22)(q21;q14)[5]/46,
XX[11]
E6/E7/hTERT 47, XX, +20[8]/48, XX, +5, +20[4]/48,
XX, +20, +20[3]
hTERT-1 47, XX, +5[10]
hTERT-2 46, XX[10]
R24C/hTERT 49, XX, +5, +7, der(7)t(7;8)(q22;q13),
+20[7]/48, XX, +5, +20, del(20)(p11.2)[3]
a The different cells in this experiment were derived from the same
normal HAE cell strain. E7/hTERT-1 and E7/hTERT-2 as well as hTERT-1
and hTERT-2 represent derivatives that were generated in independent
retroviral transductions. Cells were karyotyped between 80 and 90 pd.
b At least 10 metaphase spreads were karyotyped in detail. Number in
brackets represents the number of metaphases with that particular
karyotype.
c Vector alone did not have an extended lifespan and was karyotyped at
approximately 8 pd post-transduction.
d This is a composite (cp) karyotype. The range of 95–105 is due to
heterogeneity in the population with the modal number of chromosomes
being 98. The range of chromosome 20 copies was 6–7 with a modal
number of 6.
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2003). In that study, data analysis with Affymetrix software
indicated that a large number of cellular genes were affected
by E6 and/or E7 expression within 3–4 passages after
introduction of the genes into the cells by retroviral
transduction. To determine whether genes from specific
chromosome regions or functional groups were upregulated
in early passage E7 expressing cells, we reanalyzed the
Affymetrix expression data by using a software program
called D-Chip, which was recently developed at Harvard (Li
and Wong, 2001). This program allows an assessment of
statistically significant gene clusters based on function and
genome map location (see Materials and methods). We
focused on those genes that were upregulated by 3-fold or
more in E7 expressing cells. This resulted in assignment of
several functionally significant clusters, mostly related to
DNA metabolism and replication, as might be expected of
cells in which pRb has been inactivated. Strikingly, the only
two genome location clusters that were statistically signifi-
cant contained genes on chromosome 20q and chromosome
5 (Table 3). Karyotype analysis of the early passage E7
expressing HFK (i.e., within 3 passages after retroviral
transduction) revealed that these cells contained extra copies
of chromosome 20 and chromosome 5 in a significant
fraction of the metaphase spreads (Table 2), whereas vector
control cells were normal. Thus, induction of extra copies of
chromosomes 20q and 5 occurred at a relatively early stage
in E7 expressing HFKs and was not necessarily associatedwith extension of lifespan or immortalization, as HFKs that
expressed E7 alone eventually senesced.Discussion
Amplification of the 20q11–13 region has been impli-
cated as a critical event in the transformation of certain
epithelial cell types, including uroepithelial and mammary
epithelial cells (Cuthill et al., 1999; Hodgson et al., 2003).
Our current study indicates that amplification of 20q is also
associated with HPV-mediated extension of lifespan and
immortalization of airway and foreskin epithelial cells.
Several genes which map to the 20q11–13 region have been
identified as potential oncogenes that are amplified during
bladder and breast carcinogenesis, but the role of these
genes in the development of cancer is not completely clear
(Collins et al., 1998; Guo et al., 2004). Our studies suggest
that 20q amplification and upregulation of genes on
chromosome 20q may be a specific consequence of HPV
E7 expression and inactivation of pRb.
The mechanism of 20q amplification in E7 expressing
cells remains unknown. In the generation of many of the cell
lines in our study, there was never an apparent crisis,
suggesting that chromosome 20 aberrations occur at high
frequency. E7’s role in causing centrosome defects and
inducing genetic instability certainly could play a role in this
process (Duensing and Munger, 2002; Duensing et al.,
2001). It is interesting to note that both E7/hTERT-1 HAE
and E7/hTERT HFK were tetraploid, as might be expected
in cells with abnormal centrosome regulation. Since one of
the main functions of E7 is the inactivation of pRb, it can be
speculated that inactivation of the pRb pathway is somehow
involved in the development of 20q abnormalities. Our
studies using the dominant-negative cdk4 construct support
this hypothesis. Interestingly, extra copies of chromosome
20 were also observed in a recent study in which bronchial
epithelial cells were immortalized by co-expression of
hTERT and wild-type cdk4, which would also be expected
to inactivate the pRb pathway (Ramirez et al., 2004).
Recently, a model has been proposed to explain how
defects in the pRb pathway promote genetic instability
(Hernando et al., 2004). In this model, pRb inactivation
leads to deregulation of E2F transcription factors, which
results in upregulation of Mad2, a mitotic checkpoint
protein. Aberrant Mad2 expression can promote mitotic
defects that lead to aneuploidy. Thus, inactivation of pRb by
E7 may be involved in generating chromosome defects, but
how this relates to the development of chromosome 20q
abnormalities specifically is unknown. It is interesting to
note that, in our experiments, E7/hTERT cells had a slower
growth rate overall than E6/hTERT, E6/E7/hTERT, or E6/
E7 cells. One possibility is that abrogation of the pRb
pathway may also lead to a condition that leads to a growth
block that must be compensated for by amplification of a
gene or genes on chromosome 20. Expression of E6 may
Fig. 2. Amplification of 20q in E7 expressing human airway epithelial (HAE) cells. (A) Interphase FISH of E6/E7/TERT airway epithelial cells using dual-
color 20q and 20cen probes. This particular cell shows three copies of 20cen signal (green) and multiple copies of 20q signals (red). (B) Composite graph
showing ratios of signal from a 20q probe over signal from a 20cen probe in the various HAE lines. Two hundred or more nuclei were examined for each cell
type. Note that any cell line that expressed E7 exhibited amplification of 20q signals as compared to 20cen signals.
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study, cells that expressed hTERT alone did not exhibit 20q
amplification, even though they exhibited a significant crisis
before becoming apparently immortal. No apparent defects
in the pRb pathway, including loss of p16INK4a, were
detected in the hTERT HAE cells (data not shown).
However, loss of p16INK4a was observed in hTERT
immortalized HFK, but these cells did not exhibit chromo-
some 20 abnormalities (Farwell et al., 2000; Kiyono et al.,
1998). Thus, p16INK4a loss, unlike constitutive expression of
cdk4, may not be associated with induction of chromosome
20 abnormalities. Further work, using other factors that
inactivate the pRb pathways, and the identification and
characterization of genes on 20q that are specifically
upregulated during immortalization will be useful in under-
standing the mechanism and function of 20q amplification.Clearly, other genetic abnormalities besides chromosome
20q amplification are important for the malignant progres-
sion of HPV-infected cells. In addition to chromosome 20
abnormalities, we also consistently observed extra copies of
chromosome 5 in our HAE and HFK cell lines. Whether
amplification of genes on chromosome 5 is important for
immortalization of HAE or HFK is unknown. In a recent
study, chromosome 5 abnormalities were observed in airway
epithelial cells that were immortalized by expression of
hTERT alone (Piao et al., 2005). We also observed extra
copies of chromosome 5 in our hTERT-transduced HAE,
but this was not apparent in E6/hTERT HAE or hTERT
HFK, indicating that hTERT expression and chromosome 5
alterations are unrelated. Interestingly, chromosome 5
alterations have also been observed in a number of different
cancers, including head and neck cancers (Gollin, 2001).
Table 3
Genes upregulated 3 or more fold in E7 keratinocytes that map to
chromosome 20q or chromosome 5
Upregulated chromosome 20q genes
TAF4A RNA polymerase II, TBP-associated factor
Protein kinase C binding protein 1
Nuclear receptor coactivator 6
Splicing factor (CC1.3)
Tumor differentially expressed 1
RAE1 RNA export 1 homolog
Table 2
Karyotype analysis of HFK cells
Cell type Karyotypea
Normalb 46, XY[10]
E6/E7 47–49, XY, +5, +6, +11, add(19)(p13.3),
+20, 22[cp15]c
E7/hTERT 91–92, XXYY, 15, +20, +20, 22,
+mar[cp10]c
hTERTb 47, XY, iso(9)(q)[10]
R24C/hTERT 49, XY, +1, add(1)(q22), del(7)(q22q32),
+20, +mar[10]
Vectord 46, XY[10]
E7d 48, XY, +9, +20[10]/48, XY, +5, +20[5]
a At least 10 metaphase spreads were karyotyped in detail. Number in
brackets represents the number of metaphases with that particular
karyotype.
b Reported previously (Farwell et al., 2000). Cells were derived from the
same individual.
c These are composite (cp) karyotypes. The ranges of 47–49 for E6/E7
and 91–92 for E7/hTERT are due to heterogeneity in the population with
modal numbers being 47 and 91, respectively. Listed aberrations were
found in the majority of metaphase spreads. All E6/E7 cells contained 3
copies of chromosome 20, whereas the range of chromosome 20 copies in
E7/hTERT was 4–7 with a modal number of 6.
d Karyotypes were performed on vector and E7 cells within 8 populations
doublings post-transduction and selection.
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and -negative cancers, such as head and neck cancers, will
be useful for determining which genetic alterations are
specifically associated with HPV infection in vivo and
which ones are not. These studies could lead to the
discovery of novel genes that may be involved in the
development of HPV-associated cancer. They may also
provide valuable information that could be used for better
diagnosis and treatment of HPV-positive and -negative
malignancies.
Upregulated chromosome 5 genes
Chondroitan sulfate proteoglycan 2 (Versican)
Phosphoinositol-3-kinase, regulatory subunit
KIAA0073 protein
Transcription factor IIF
X-ray repair gene
Fer tyrosine kinase NCP94
Thyroid hormone receptor coactivating protein
Cyclophilin C
3-Oxoacid CoA transferase
Cyclin H
Forkhead Box D1
IK cytokine downregulator of HLA II
Beta-2 adrenergic receptor
MAP kinase 9
Death-associated protein
TAF7 RNA polymerase (II), TBP-associated factor
Purine-rich element binding protein A
Aldehyde dehydrogenase 7
Hydroxysteroid dehydrogenase 4
LNS-CAI/LNS-CAII
Calcium modulating ligand
KIAA0202 protein
ADP-ribosylation factor domain protein 1
Ras p21 protein activator 1
Histidyl– tRNA synthetaseMaterials and methods
Generation of cell lines
Human airway epithelial cells (HAE) used in this study
were isolated from bronchial or tracheal tissue of normal
adult cadaver specimens and human foreskin keratinocytes
(HFK) were obtained from foreskin tissue of neonates in
accordance with protocols approved by the University of
Iowa Institutional Review Board and HIPAA guidelines.
HAE cells were isolated and grown as previously described
in bronchial epithelial growth medium (BEGM, Cambrex)
on placental collagen (type VI)-coated plates (Karp et al.,
2002). HFK were grown in keratinocyte serum-free media
(KSFM, Invitrogen) as described (Klingelhutz et al., 1994).
For transduction of exogenous genes, primary cells at
passages 2–3 post-isolation were infected as described
(Farwell et al., 2000; Kiyono et al., 1998; Zabner et al.,
2003) with various retrovirus constructs in combinations
that allowed for selection in hygromycin (10 Ag/ml) orG418 (50 Ag/ml). The LXSN, LXSH, 16 E7 LXSH, and 16
E6 LXSN, and 16 E6/E7 LXSN replication-incompetent
MLV retroviral constructs were obtained from Denise
Galloway (Fred Hutchinson Cancer Research Center). The
hTERT neo pBABE and hTERT hygro-pBABE replication-
incompetent retroviral constructs were obtained from Robert
Weinberg (Whitehead Institute), and the retroviral construct
expressing a dominant-negative cdk4 (R24C) was obtained
from William Hahn (Harvard). Cells infected with single
vectors were selected for 8 days after infection in the
appropriate antibiotic. Cells infected with two vectors were
sequentially selected. All cell lines were checked for
expression of various genes by RT-PCR or Western blot
and for telomerase activity as previously described (Sprague
et al., 2002; Zabner et al., 2003). Culture splits were 1:6 for
HAE and 1:5 for HFK. Cells were passaged until
senescence or until they had exceeded 100 populations
doublings or more, which is approximately 2.5- to 3.0-fold
their normal lifespan in these culture conditions.
Cytogenetic and FISH analyses
Chromosomal analyses were performed on HAE cells
from in situ cultures harvested on coverslips by TeCan
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were arrested in metaphase by adding ethidium bromide
(final concentration12.5 Ag/ml) for 40 min followed by
colcemid (final concentration 6 Ag/ml). After 1–2 h, the
cells were incubated for 25 min at room temperature with
hypotonic solution (3:1 mixture of 0.8% sodium citrate and
0.075 molar potassium chloride). Cells were then fixed
three times with a 3:1 methanol/acetic acid. Chromosome
spreading on coverslips was done on Thermotron and
mounted on glass slides after the drying process. Ten to
twenty G-banded metaphases were analyzed for each cell
type. Karyotypes were performed for most cells (except
normal, vector, and early passage E7 cells) after they had
reached 80–90 pd or approximately 2- to 2.5-fold beyond
their normal lifespan. The images were captured and
karyotyped in CytoVision computerized imaging system
(Applied Imaging, USA).
For FISH analysis, probes for the 20q subtelomeric
(mixture #15), 20q12, and a chromosome 20 centromeric
region probe, 20cen (VYSIS, Downer’s Grove, IL, USA),
were used in this study. The 20q12 probe (D20S108) has
been previously used to define the region of 20q
amplification in breast cancer (Collins et al., 1998).
Chromosome 5p and 5cen probes (Vysis) were also used
for several of the analyses. Protocols were followed
according to manufacturer’s specifications. Briefly, hybrid-
ization was performed on Hybrite programmed for melt
temperature at 75 -C and time for 1 min. After overnight
hybridization at 37 -C, the slides were washed in 0.4
SSC/0.3% NP-40 for 2 min at 72 -C and in 2 SSC/0.1%
NP-40 for 1 min at room temperature. The slides were then
counterstained with DAPI. For each cell line, five
metaphases cells and over 200 interphase nuclei were
analyzed. The image acquisition was also through CytoVi-
sion. Counts of signals were made for the various probes
and amplification of signals in the 20q region was
compared to signals from the 20cen region.
Microarrays
Microarray analysis was done as described previously
(Duffy et al., 2003) using Affymetrix HuFL arrays. Data
were initially analyzed using Affymetrix Microarray Suite
software. The data in CEL format (Affymetrix Protocol)
were then normalized and analyzed by using dChip
version 1.3 software (Harvard) (Li and Wong, 2001).
This program allows an assessment of functionally
significant gene clusters using GeneOntology terms, as
well as an assessment of significant clusters of genes that
map to specific chromosome locations (see http://www.
biostat.harvard.edu/complab/dchip/clustering.htm for a
detailed explanation of how significance is established).
P values smaller than 0.001 are considered significant.
Only those genes that were upregulated by 3-fold or more
in E7-expressing cells were included in the clustering
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